CNN CNN Newsroom With Alisyn Camerota and Victor Blackwell February 11, 2022 20:42:00
More data showing three doses was effective compared to two doses which is what the authorization submission was for then we swrwould have to go thrh the process. the fda says more data has come out on the vaccine. they are waiting until possibly april to do the authorization process once more data come in. the data i'm talking about, it turns out that pfizer study on the vaccine as a three dose series instead of two dose is moving quickly and while the original eua submission was for two doses, it turns out with the data or three doses, that can be considered later on. that's what's happening...